On the other hand, virally transformed tumorigenic mammary epithelial cell lines as well as most of the cell lines derived from invasive human breast carcinomas are resistant to the antiproliferative effects of TGFβ1 in vitro and do not respond to treatment with TGFβ1 in vivo. The gene discussed is TGFB1; the disease is breast carcinoma.